Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

MGX

Metagenomi Therapeutics, Inc.

CIK 0001785279 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$1.26
↓ 0.03 (-2.33%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$47.44M
P/E Ratio
-0.55
EPS
-2.36
Dividend Yield
Not covered
52W Position
5%
Beta
1.75

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.34
P/S
2.12
EV/Revenue
0.99
ROE
-62.3%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 5%
$1.13$3.95

Latest Financials

2025-12-31 FY
Revenue
$25.21M
Net Income
-$87.87M
Total Assets
$221.10M
Free Cash Flow
-$89.47M

Recent news